MarketPeel
Insider Trading Intelligence
TI

Takeda Ventures, Inc.

DAWN
10% OWNER · DAY ONE BIOPHARMACEUTICALS, INC. · CIK 0001771657
FILING MIX · LIFETIME22%/78%
BUYS
2
SELLS
7
TOTAL VALUE
$7.49M
COMPANIES
2
ACTIVE SINCE
Oct 2021
HOLDINGS NOW
6,120,124
AVG SELL PX
$18.38
TRADE KIND
SHOWING 9 / 9
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Takeda Ventures, Inc., measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+80.00%-2.21%+0.73%-2.94%-2.01%
14d5+100.00%-4.38%-0.05%-4.33%-3.18%
30d5+100.00%-7.94%+1.67%-9.61%-8.84%
60d5+100.00%-21.78%-2.74%-19.04%-19.82%
90d5+100.00%-31.20%-8.62%-22.58%-21.94%
180d5+100.00%-62.64%-10.73%-51.91%-51.41%
1y5+0.00%+20.87%-13.12%+33.99%+36.46%
2y5+100.00%-31.56%+1.79%-33.35%-32.83%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
DAWN · 6,120,124 shares · as of Dec 8, 2021
01,631,9023,263,8034,895,7056,527,606SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2021
FLOW · 2 buys / 7 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
DAWN
DAY ONE BIOPHARMACEUTICALS, INC.
SALE
110,338$18.03$1.99M6,120,124Dec 8, 2021Dec 9, 2021
DAWN
DAY ONE BIOPHARMACEUTICALS, INC.
SALE
128,745$18.43$2.37M6,288,652Dec 7, 2021Dec 9, 2021
DAWN
DAY ONE BIOPHARMACEUTICALS, INC.
SALE
58,190$19.50$1.13M6,230,462Dec 7, 2021Dec 9, 2021
DAWN
DAY ONE BIOPHARMACEUTICALS, INC.
SALE
97,692$18.05$1.76M6,417,397Dec 6, 2021Dec 7, 2021
DAWN
DAY ONE BIOPHARMACEUTICALS, INC.
SALE
12,517$18.47$231.2K6,515,089Dec 3, 2021Dec 7, 2021
DAWN
DAY ONE BIOPHARMACEUTICALS, INC.
PURCHASE
57,2246,527,606Nov 24, 2021Nov 29, 2021
XLO
XILIO THERAPEUTICS, INC.
SALE
1,248,1800Oct 26, 2021Oct 26, 2021
XLO
XILIO THERAPEUTICS, INC.
PURCHASE
1,475,1211,475,121Oct 26, 2021Oct 26, 2021
XLO
XILIO THERAPEUTICS, INC.
SALE
226,9410Oct 26, 2021Oct 26, 2021
Other insiders · DAWN
Loading peer insiders…
About this filer
CIK 0001771657
ROLE
10% Owner
PRIMARY
DAWN
COMPANIES
2
ACTIVE SINCE
Oct 2021
MARKETPEEL · /INSIDER/0001771657DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

FeedbackTakeda Ventures, Inc. — Insider Trading Activity | MarketPeel